Yungjin Pharm. Market Cap

Yungjin Pharm. has a market cap or net worth of 366.70 billion as of May 13, 2025. Its market cap has decreased by -0.74% in one year.

Market Cap

366.70B

Enterprise Value

n/a

Revenue

158.79B

Ranking

n/a

PE Ratio

37.48

Stock Price

2,005.00

Market Cap Chart

Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 366.70B, an increase of 493.33%. That is a compound annual growth rate of 5.70%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	366.70B	0.86%
Dec 30, 2024	363.59B	-6.45%
Dec 28, 2023	388.65B	-34.62%
Dec 29, 2022	594.40B	-38.56%
Dec 30, 2021	967.50B	-34.20%
Dec 30, 2020	1,470.46B	21.27%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.02T
Celltrion	33.69T
ALTEOGEN	18.39T
Yuhan	8,026.78B
HLB Co., Ltd.	7,581.42B
SK Biopharmaceuticals	7,079.52B
PharmaResearch	4,171.44B
Peptron	3,872.02B

Market Cap Rankings